期刊文献+

噬菌体治疗制剂的研究进展 被引量:8

Advance in bacteriophages as therapeutic agents
在线阅读 下载PDF
导出
摘要 从噬菌体作为治疗制剂的前提条件、噬菌体的药物动力学特征、噬菌体可能携带的有害基因、噬菌体产物、噬菌体治疗的实例等方面综述了噬菌体作为治疗制剂的研究进展,旨在通过介绍用噬菌体替代抗生素治疗由细菌引起的感染的机理,为细菌性疾病的治疗提供新的思路和方法。 Research progress of bacteriophages as therapeutic agents was reviewed from the aspects of prerequisites for phage therapy, phage pharmacokinetics, carrying harmful genes of phage, phage products,recent in vivo phage studies, with the objective of providing new methods and ideas of bacteriophages as antimicrobial agents which could take place of antibiotics to control bacterial infections.
出处 《中国兽医科学》 CAS CSCD 北大核心 2007年第7期641-644,共4页 Chinese Veterinary Science
基金 国家自然科学基金项目(30571384)
关键词 噬菌体 治疗制剂 细菌感染 bacteriophage therapeutic agent bacterial infection
  • 相关文献

参考文献18

  • 1PELKONEN S,AALTO J,FINNE J,et al.Differential activities of bacteriophage depolymerase on bacterial polysaccharide:binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli[J].Bacterial,1992,174(23):7757-7761.
  • 2朱召芹,阚飙,高守一.噬菌体裂解系统及其相关蛋白的研究进展[J].中国预防医学杂志,2004,5(6):495-498. 被引量:8
  • 3LEVIN B R,BULL J J.Population and evolutionary dynamics of phage therapy[J].Nat Rev Microbiol,2004,2(2):166-173.
  • 4PAYNE R J,JANSEN V A.Pharmacokinetic principles of bacteriophage therapy[J].Clin Pharmacokinet,2003,42(4):315-325.
  • 5WELD R J,BUTTS C,HEINEMANN J A.Models of phage growth and their applicability to phage therapy[J].Theor Biol,2004,227(1):1-11.
  • 6FISCHER C R,YOICHI M,UNNO H,et al.The coexistence of Escherichia coli serotype O157:H7 and its specific bacteriophage in continuous culture[J].FEMS Microbiol Lett,2004,241(2):171-177.
  • 7MESYANZHINOV V V,ROBBEN J,GRYMONPREZ B,etal.The genome of bacteriophage fKZ of Pseudomonas aeruginosa[J].Mol Biol,2002,317(1):1-19.
  • 8严亚贤,陆承平.大肠杆菌VT2噬菌体的分离与溶源转染[J].中国病毒学,2004,19(4):389-393. 被引量:4
  • 9SCHUCH R,NELSON D,FISCHETTI V A.A bacteriolytic agent that detects and kills Bacillus anthracis[J].Nature,2002,418(6900):884-889.
  • 10STRAUCH E,KASPAR H,SCHAUDINN C,et al.Characterization of enterocoliticin,a phage tail-like bacteriocin,and its effect on pathogenic Yersinia enterocolitica strains[J].Appl Environ Microbiol,2001,67(12):5634-5642.

二级参考文献36

  • 1Michino H, Araki K, Minami S, et al. Recent outbreaks of infections caused by Escherichia coli O157:H7 in Japan. In Escherichia coli O157:H7 and Other Shiga-Toxin-Producing E. coli Strains [M].Washington, DC: American Society for Microbiology. 1998, p59-8
  • 2Schmidt H. Shiga-toxin-converting bacteriophages[J]. Res Microbiol,2001, 152: 687-695.
  • 3O'Brien A D, Holmes R K. Shiga and shiga-like toxins[J]. Microbiol Rev, 1987, 51: 206-220.
  • 4Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual (2nd edn) [M]. 1989, Cold spring Harbour, N.Y: Cold spring Harbour Laboratory.
  • 5James, C E, Stanley N, Allison H E, et al. Lyric and Lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage [J]. Appl Envir Microbiol, 2001, 67:4335-4337.
  • 6Boerlin P, McEwen S A, Boerlin-Petzold F, et al. Association between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans[J]. J Clin Microbiol, 1999, 37:497-503.
  • 7Muniesa M, Recktenwald J, Bielasewska M, et al. Characterization of a Shiga Toxin 2e-converting Bacteriophage from an Escherichia coli Strain of Human Origin[J]. Infect Immun, 2000, 68: 4850-4855.
  • 8Ohnishi M, Kurokawa K, Hayashi T. Diversification of Escherichia coli genomes: are bacteriophages the major contributors? [J]. TRENDS in Microbiol, 2001, 9(10): 481-485.
  • 9Keusch G The rediscovery of shiga toxin and it's role in clinical disease[J]. Jap J Med Sci biol. 1998, 51:5-22.
  • 10Rietra P J G M, Willshaw G A, Smith H R, et al. Comparison of Vero-cytotoxin encoding phages from Escherichia coli of human and bovine origin[J]. J Gen Microbiol, 1989, 135: 2307-2318.

共引文献10

同被引文献104

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部